L
3680
A new personalized vaccine against melanoma, Intismeran autogene, has been shown to significantly reduce the risk of recurrence and metastasis in patients undergoing combined treatment with immunotherapy, as highlighted by the INTerpath-001 study presented at the ESMO congress in Madrid. #VaccinoMelanoma #Immunoterapia #ESMO2026 (translated)
www.lastampa.it
Melanoma, svolta nella lotta al tumore: il vaccino personalizzato funziona: ecco come agisce
